Standardized Postnatal Management of Infants With Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update
Standardized Postnatal Management of Infants With Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update
Standardized Postnatal Management of Infants With Congenital Diaphragmatic Hernia in Europe: The CDH EURO Consortium Consensus - 2015 Update
a
Erasmus MC – Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, and b Radboud University
Medical Centre, Nijmegen, The Netherlands; c King’s College and d University College London Hospitals, London, UK;
e
Bambino Gesu Children’s Hospital, Rome, Italy; f Medical University Graz, Graz, Austria; g Universitätsklinikum Mannheim,
Mannheim, Germany; h Hôpital Jeanne de Flandre, Lille, France; i University Hospital KU Leuven, Leuven, Belgium
Abstract
In 2010, the congenital diaphragmatic hernia (CDH) EURO
Consortium published a standardized neonatal treatment Introduction
protocol. Five years later, the number of participating cen-
ters has been raised from 13 to 22. In this article the relevant In 2008, the congenital diaphragmatic hernia (CDH)
literature is updated, and consensus has been reached be- EURO Consortium was set up and during a consensus
tween the members of the CDH EURO Consortium. Key up- meeting drafted a standardized neonatal treatment pro-
dated recommendations are: (1) planned delivery after a tocol to improve outcome and permit comparison of
gestational age of 39 weeks in a high-volume tertiary center; outcome data [1]. Since then the number of participat-
(2) neuromuscular blocking agents to be avoided during ini- ing centers has increased from 13 to 22 specialized CDH
tial treatment in the delivery room; (3) adapt treatment to centers from all over Europe, and the guidelines from
reach a preductal saturation of between 80 and 95% and 2010 have been widely cited. Moreover, after the imple-
postductal saturation >70%; (4) target PaCO2 to be between mentation of the protocol, the survival rate has increased
50 and 70 mm Hg; (5) conventional mechanical ventilation from 67 to 88% in 2 centers. This indicates the impact of
to be the optimal initial ventilation strategy, and (6) intrave- the original standardized protocol. After 5 years of ad-
ditional research including a multicenter randomized
clinical trial on initial ventilation strategy (VICI-trial;
The Members of the CDH EURO Consortium Group are listed in the Netherlands Trial Register, NTR 1310), we aimed to up-
UFRJ Universidade Federal do Rio de Janeiro
E-Mail [email protected]
This article is licensed under the Creative Commons Attribution- Room Sk-3284, PO Box 3060, NL–3000 CB Rotterdam (The Netherlands)
www.karger.com/neo
NonCommercial-NoDerivatives 4.0 International License (CC BY- E-Mail d.tibboel @ erasmusmc.nl
NC-ND) (http://www.karger.com/Services/OpenAccessLicense).
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
CDH. All recommendations were summarized and ever, but may ultimately improve the predictive value of
compared with the protocol in 2010 (online suppl. file; prenatal testing.
see www.karger.com/doi/10.1159/000444210 for all on- An experienced tertiary center with a high case volume
line suppl. material). (≥6 CDH patients per year) is the optimal environment
for the delivery and neonatal treatment of prenatally diag-
nosed CDH fetuses [9, 10]. Prenatal intervention by fetal
Methods endoscopic tracheal occlusion (FETO) has been proposed
to promote lung growth [11]. Therefore, FETO is being
The studies were graded according to the Scottish Intercolle-
evaluated in two randomized clinical trials both in moder-
giate Guidelines Network (SIGN) criteria [2]. Five experts individ-
ually primarily determined the levels of evidence on the guidance ate (first interim analysis stage reached; >100 patients ran-
of the SIGN checklist. Differences in opinion were primarily dis- domized) and severe cases (>25 patients randomized) in
cussed between the five experts until full consensus was reached, centers in Europe, Australia and Canada (TOTAL trial
and thereafter consensus was reached between all participating cen- [12]; NCT01240057). Current reported survival rates are
ters. The final consensus statement, therefore, represents the opin-
on average around 50%, yet there is a significant impact of
ion of all participating centers based on the interpretation of the
recent literature from 2010 to 2015 and includes the main findings gestational age at delivery. In the largest cohort study
of the so-called VICI-trial [3]. A consensus meeting, in which neo- where 17.1% of all patients were born under 32 weeks, the
natologists, pediatric intensivists, gynecologists, prenatal physi- survival rate was 49.4% for isolated left CDH and 37.9%
cians, pediatric surgeons, pediatric cardiologists and general pedia- for isolated right CDH [13]. This suggests that FETO in-
tricians from 22 centers participated, was organized to discuss the
troduces a significant risk for prematurity and all its con-
most controversial recommendations. If it was very hard to reach
consensus on a specific issue, the consortium concurred to investi- sequences. It is recommended therefore that – while wait-
gate those issues in future randomized trials. The levels of evidence ing for the results – FETO should not be performed out-
and grades of recommendation according to the SIGN criteria are side the trial [11]. According to the consensus statement
presented in online supplementary tables 1 and 2, respectively. of the National Institutes of Health (NIH), CDH fetuses at
risk for delivery before 34 weeks of gestation should be
given prenatal steroid therapy.
Results
Delivery
Prenatal Management The timing and preferred mode of delivery in CDH
With the increased use of second trimester 2D ultra- pregnancies are still controversial. Hutcheon et al. [14]
sound and/or MRI, CDH has become a prenatal diagno- showed that neonatal and infant mortality significantly
sis. Subsequently, a more detailed expert evaluation decreased with advancing gestation, from 25 and 36% at
should be performed to determine the location of the de- 37 weeks of gestation, respectively, to 17 and 20% at 40
fect, the observed/expected lung-to-head ratio (O/E weeks of gestation, respectively. Moreover, a study from
LHR) and the position of the liver (intra-abdominal or Odibo et al. [15] among 107 CDH cases found that gesta-
intrathoracic), in addition to ruling out additional con- tional age at delivery was inversely correlated to the need
genital anomalies or syndromes [4, 5]. Associated con- for ECMO. However, Safavi et al. [16] found no differ-
genital anomalies, such as chromosomal or genitourinary ence in mortality when dividing gestational age at deliv-
anomalies, are present in about 25% [6] and cardiac ery categorically as under 37 weeks, 37–38 weeks and 39
anomalies in about 20% of cases [7]. Comprehensive as- weeks or beyond. Neither did they find a difference in
sessment will also include invasive sampling for high-res- mortality between vaginal and cesarean delivery [16]. In
olution genetic testing. Only once a comprehensive as- the absence of true convincing data it seems intuitive to
sessment has been made can multidisciplinary prenatal schedule delivery (induced delivery or cesarean section)
counseling by clinicians in tertiary centers be offered to carefully in the best possible conditions also dependent of
inform parents about the estimated prognosis after birth. maternal indications, i.e. at 39 weeks or beyond and in the
Several other additional imaging methods, such as lung presence of the relevant clinicians.
volumetry, 3D ultrasound and Doppler studies of the pul-
monary vascularization, have been shown in individual Recommendations (Prenatal Management and
series to be prognostic for pulmonary hypertension, the Delivery)
need for extracorporeal membrane oxygenation (ECMO) – Following prenatal diagnosis, disease severity should
UFRJ Universidade Federal do Rio de Janeiro
and survival [8]. All of these remain research tools, how- be assessed at an experienced center. This will involve
146.164.3.22 - 6/23/2016 8:57:21 PM
dicted to have good lung development based on their pre- blood pressure at normal levels for gestational age if pre-
146.164.3.22 - 6/23/2016 8:57:21 PM
DOI: 10.1159/000444210
Downloaded by:
ductal saturations remain between 80 and 95%. In the Ventilation Management in the Intensive Care Unit
case of hypotension and/or poor tissue perfusion, a fluid Permissive hypercapnia and ‘gentle ventilation’ have
bolus of 10–20 ml/kg NaCl 0.9% should be administered, been reported to increase survival in neonates with CDH
although no more than 2 times. If tissue perfusion and [28, 29]. A ventilation strategy aiming for preductal satu-
blood pressure do not improve, inotropic and/or vaso- ration between 80 and 95%, postductal saturation above
pressor medication should be considered according to lo- 70% and arterial CO2 levels between 50 and 70 mm Hg
cal practice. Hydrocortisone may be used in the early (6.9–9.3 kPa, permissive hypercapnia) is well accepted. In
phase for the treatment of hypotension after other treat- the first 2 h after birth, preductal SpO2 levels as low as 70%
ment has failed [26]. are acceptable provided they are slowly improving and
organ perfusion is satisfactory (indicated by a pH >7.2),
Surfactant and if ventilation is adequate (PaCO2 <65 mm Hg, 8.6
There is no rationale for surfactant therapy because in kPa). Thereafter, preductal saturation levels are prefera-
CDH patients surfactant amounts are likely to be appro- bly kept between 85 and 95%. In individual cases, how-
priate to lung size [27]. ever, levels down to 80% may be accepted, providing or-
gans are well perfused, as indicated by a pH >7.2, lactate
Recommendations levels <5 mmol/l and urinary output >1 ml/kg/h. Post-
– After delivery, the infant should be intubated routine- ductal saturations should remain above 70%. Oxygen
ly without bag and mask ventilation (grade of recom- toxicity can be avoided by decreasing FiO2 on the guid-
mendation = D). ance of the saturation levels described above. The optimal
– The goal of treatment in the delivery room is achieving initial ventilation strategy was investigated in a collab-
acceptable preductal saturation targets, i.e. between 80 orative initiative from the CDH EURO Consortium
and 95% (grade of recommendation = D). (VICI-trial, NTR 1310) [30]. Although the primary out-
– Ventilation in the delivery room should be done with come (death/bronchopulmonary dysplasia at day 28) was
a peak pressure as low as possible, preferably with 25 not significantly different between the two groups, it was
cm H2O, or below that (grade of recommendation = found that infants initially ventilated by conventional
D). mechanical ventilation required a significantly shorter
– An oro- or nasogastric tube with continuous or inter- duration of ventilation, had less need for inhaled nitric
mittent suction should be placed (grade of recommen- oxide (iNO) or sildenafil, had a shorter duration of vaso-
dation = D). active medication and were less likely to require ECMO
– Arterial blood pressure has to be maintained at a nor- [3]. Therefore, the CDH EURO Consortium recom-
mal level for gestation. In the case of hypotension and/ mends conventional mechanical ventilation as the initial
or poor tissue perfusion, 10–20 ml/kg NaCl 0.9% ventilation strategy. Recommendations for initial ventila-
should be administered 2 times (grade of recommen- tion settings for pressure-controlled ventilation are sum-
dation = D). marized below. In the case of weaning, the peak pressure
– In cases of persistent hypotension after the adminis- should primarily be reduced. Thereafter, frequency or
tration of NaCl 0.9%, inotropic and vasopressor agents PIP/PEEP may be reduced as long as pCO2 <50 mmHg
should be considered (grade of recommendation = D). (6.7 kPa). In general, the consortium recommends aim-
– In CDH infants who are predicted to have good lung ing for a limitation of peak pressure to 25 cm H2O or less,
development based on their prenatal assessment (e.g. a PEEP of 3–5 cm H2O and adjustment of the ventilator
left-sided defect, O/E LHR >50%, and liver down), rate to obtain PaCO2 between 50 and 70 mm Hg (6.9–9.3
spontaneous breathing could be considered (grade of kPa). If a PIP of >28 cm H2O is necessary to achieve pCO2
recommendation = D). and saturation levels within the target range, other treat-
– Premedication should be given before intubation if ment modalities (such as high-frequency oscillatory ven-
possible (grade of recommendation = D). tilation or ECMO) should be considered.
– Neuromuscular blocking agents should be avoided
during initial treatment in the delivery room (grade of Chest Radiograph
recommendation = D). To assess the patient’s initial condition, a chest radio-
– No routine use of surfactant in either term or preterm graph should be obtained as soon as possible.
infants with CDH (grade of recommendation = D).
UFRJ Universidade Federal do Rio de Janeiro
146.164.3.22 - 6/23/2016 8:57:21 PM
DOI: 10.1159/000444210
Downloaded by:
ing inotropic or vasopressor agents such as dopamine, do- of 10–20% of PaO2, or improvement in hemodynamic
butamine and (nor)epinephrine to maintain blood pres- parameters meaning a 10% increase in mean blood
sure at normal levels for gestation [40]. If preductal satu- pressure, or a decrease in lactate levels (grade of rec-
ration falls below 85% and/or if there are signs of poor ommendation = D).
organ perfusion, treatment of pulmonary hypertension – Intravenous sildenafil should be considered in CDH
should be initiated. The first choice would be iNO, which patients with severe pulmonary hypertension (grade
is a pulmonary vasodilator. In neonates with pulmonary of recommendation = D).
hypertension of the newborn (PPHN) or severe hypoxic – In case of suprasystemic pulmonary artery pressure
respiratory failure, iNO improves oxygenation and de- and right-to-left shunting through the foramen ovale,
creases the need for ECMO [41, 42]. At an oxygenation intravenous prostaglandin E1 should be considered
index of 20 or higher and/or a pre- and postductal satura- (grade of recommendation = D).
tion difference of 10% or more, iNO may be given for at
least 1 h. A consistent dose-dependent effect of iNO has Extracorporeal Membrane Oxygenation
not yet been shown [43]. As in one study more infants The benefit of ECMO in the treatment of infants with
treated with NO needed ECMO [43], we recommend CDH remains unclear. The ELSO registry showed a sur-
stopping iNO therapy if no effect is seen after its initiation. vival rate of 51% of patients with CDH who required
If there is no or an insufficient response to iNO, intra- ECMO [49]. The use of ECMO has decreased in recent
venous prostacyclin, intravenous phosphodiesterase type years [50]; it is more used for preoperative stabilization,
5 inhibitor (sildenafil) or medication involving the endo- and the preferred method (venoarterial vs. venovenous)
thelin pathway should be considered. These agents have is still being debated. The VICI-trial showed no difference
been used successfully in treating PPHN in neonates with in survival between patients born in ECMO centers and
and without CDH [44, 45]. The effects of treatment may patients born in non-ECMO centers [3].
be best addressed by repeated cardiac evaluation [46].
This can lead to insufficient filling of the left ventricle and Recommendations
thereby to poor systemic perfusion. Reopening of the – Criteria for ECMO (grade of recommendation = D):
ductus arteriosus with prostaglandin E1 may protect the • Inability to maintain preductal saturations >85% or
right ventricle from excessive overload due to increased postductal saturations >70%.
afterload [47]. Phosphodiesterase-3 inhibitor (Milri- • Increased PaCO2 and respiratory acidosis with pH
none) was investigated in only 6 CDH patients by Patel et <7.15 despite optimization of ventilator management.
al. [48]. Right ventricular function and oxygenation index • Peak inspiratory pressure >28 cm H2O or mean air-
significantly improved. Sildenafil has been used in the way pressure >17 cm H2O is required to achieve sat-
treatment of pulmonary hypertension in infants with uration >85%.
CDH. Intravenous sildenafil has recently become avail- • Inadequate oxygen delivery with metabolic acidosis as
able, but its use has not yet been FDA approved. measured by elevated lactate ≥5 mmol/l and pH <7.15.
• Systemic hypotension, resistant to fluid and inotro-
Recommendations pic therapy, resulting in urine output <0.5 ml/kg/h
– Perform echocardiography within the first 24 h after for at least 12–24 h.
birth to rule out structural cardiac anomalies (grade of • Oxygenation index ≥40 present for at least 3 h.
recommendation = D).
– Blood pressure support should be given to maintain Surgical Repair
arterial blood pressure levels at normal levels for gesta- Surgery should be performed electively. The effect of
tion (grade of recommendation = D). hospital volume on mortality is unclear. While a large study
– iNO administration for at least 1 h in a dose of 10–20 (2,203 infants) concluded that hospitals with a high volume
ppm should be considered if there is evidence of extra- of CDH repair have lower in-hospital mortality [51], a
pulmonary right-to-left shunting and the oxygenation more recent study in 3,738 infants showed no difference in
index is above 20 and/or the saturation difference is mortality between lower and higher surgical volume cen-
more than 10% (grade of recommendation = D). ters [52]. Controversies about the exact timing of the surgi-
– In nonresponders iNO should be stopped. iNO re- cal repair in patients on ECMO remain [53]. A recent study
sponders are defined as follows: a decline of 10–20% in from Partridge et al. [54] showed improved outcomes with
UFRJ Universidade Federal do Rio de Janeiro
the pre-postductal saturation difference, or an increase surgical repair after ECMO, i.e. a higher likelihood of sur-
146.164.3.22 - 6/23/2016 8:57:21 PM
lar filling in the case of inadequate tissue perfusion or Leva, F. Ciralli; Italy, Rome, Bambino Gesu Children’s Hospital: P.
146.164.3.22 - 6/23/2016 8:57:21 PM
DOI: 10.1159/000444210
Downloaded by:
Bagolan, I. Capolupo, A. Dotta, F. Morini, A. di Pede; Norway, don, University College London Hospitals: J. Deprest; United
Oslo, Oslo University Hospital: R. Emblem, K. Ertesvag; Poland, Kingdom, London, UCL Institute of Child Health and Great Or-
Warsaw, Centrum Zdrowia Dziecka: M. Migdal, A. Piotrowski; mond Street Hospital for Children: P. De Coppi, S. Eaton; UK,
Sweden, Stockholm, Karolinska Univeristy: B. Frenckner, C. Me- London, King’s College: M. Davenport, A. Greenough.
sas; Spain, Madrid, Hospital University La Paz: D. Elorza, L. Mar-
tinez; The Netherlands, Nijmegen, Radboud University Medical
Centre: A. van Heijst, H. Scharbatke; The Netherlands, Rotterdam,
Erasmus MC-Sophia Children’s Hospital University Medical Cen- Acknowledgment
ter Rotterdam: T. Cohen-Overbeek, A.J. Eggink, U.S. Kraemer,
I.K.M. Reiss, K.G. Snoek, D. Tibboel, R.M.H. Wijnen; UK, Lon- We thank Ko Hagoort for editing.
References
1 Reiss I, Schaible T, van den Hout L, Capolupo diaphragmatic hernia. J Pediatr Surg 2011;46: 18 Dawson JA, Kamlin CO, Vento M, Wong C,
I, Allegaert K, van Heijst A, Gorett Silva M, 814–816. Cole TJ, Donath SM, Davis PG, Morley CJ:
Greenough A, Tibboel D; CDH EURO Con- 10 Grushka JR, Laberge JM, Puligandla P, Skars- Defining the reference range for oxygen satu-
sortium: Standardized postnatal management gard ED; Canadian Pediatric Surgery Net- ration for infants after birth. Pediatrics 2010;
of infants with congenital diaphragmatic her- work: Effect of hospital case volume on out- 125:e1340–e1347.
nia in Europe: The CDH EURO Consortium come in congenital diaphragmatic hernia: the 19 Davis PG, Tan A, O’Donnell CP, Schulze A:
consensus. Neonatology 2010;98:354–364. experience of the Canadian Pediatric Surgery Resuscitation of newborn infants with 100%
2 Harbour R, Miller J: A new system for grading Network. J Pediatr Surg 2009;44:873–876. oxygen or air: a systematic review and meta-
recommendations in evidence-based guide- 11 Grivell RM, Andersen C, Dodd JM: Prenatal analysis. Lancet 2004;364:1329–1333.
lines. BMJ 2001;323:334–336. interventions for congenital diaphragmatic 20 Rabi Y, Rabi D, Yee W: Room air resuscitation
3 Snoek KG, Capolupo I, van Rosmalen J, Hout hernia for improving outcomes. Cochrane of the depressed newborn: a systematic review
LJ, Vijfhuize S, Greenough A, Wijnen RM, Database Syst Rev 2015;11:CD008925. and meta-analysis. Resuscitation 2007; 72:
Tibboel D, Reiss IK; CDH EURO Consor- 12 Deprest J, Brady P, Nicolaides K, Benachi A, 353–363.
tium: Conventional mechanical ventilation Berg C, Vermeesch J, Gardener G, Gratacos E: 21 Carbajal R, Eble B, Anand KJ: Premedication
versus high-frequency oscillatory ventilation Prenatal management of the fetus with iso- for tracheal intubation in neonates: confusion
for congenital diaphragmatic hernia: a ran- lated congenital diaphragmatic hernia in the or controversy? Semin Perinatol 2007; 31:
domized clinical trial (the VICI-trial). Ann era of the total trial. Semin Fetal Neonatal 309–317.
Surg 2015, Epub ahead of print. Med 2014;19:338–348. 22 Caldwell CD, Watterberg KL: Effect of pre-
4 Gentili A, Pasini L, Iannella E, Landuzzi V, 13 Jani JC, Nicolaides KH, Gratacos E, Valencia medication regimen on infant pain and stress
Lima M, Bacchi Reggiani ML, Baroncini S: CM, Done E, Martinez JM, Gucciardo L, Cruz response to endotracheal intubation. J Peri-
Predictive outcome indexes in neonatal con- R, Deprest JA: Severe diaphragmatic hernia natol 2015;35:415–418.
genital diaphragmatic hernia. J Matern Fetal treated by fetal endoscopic tracheal occlusion. 23 Le CN, Garey DM, Leone TA, Goodmar JK,
Neonatal Med 2015;28:1602–1607. Ultrasound Obstet Gynecol 2009;34:304–310. Rich W, Finer NN: Impact of premedication
5 Jani JC, Benachi A, Nicolaides KH, Allegaert 14 Hutcheon JA, Butler B, Lisonkova S, Mar- on neonatal intubations by pediatric and neo-
K, Gratacos E, Mazkereth R, Matis J, Tibboel quette GP, Mayer C, Skoll A, Joseph KS: Tim- natal trainees. J Perinatol 2014;34:458–460.
D, Van Heijst A, Storme L, Rousseau V, ing of delivery for pregnancies with congeni- 24 Murthy V, D’Costa W, Nicolaides K, Daven-
Greenough A, Deprest JA; Antenatal CDH tal diaphragmatic hernia. BJOG 2010; 117: port M, Fox G, Milner AD, Campbell M,
Registry Group: Prenatal prediction of neo- 1658–1662. Greenough A: Neuromuscular blockade and
natal morbidity in survivors with congenital 15 Odibo AO, Najaf T, Vachharajani A, Warner lung function during resuscitation of infants
diaphragmatic hernia: a multicenter study. B, Mathur A, Warner BW: Predictors of the with congenital diaphragmatic hernia. Neo-
Ultrasound Obstet Gynecol 2009;33:64–69. need for extracorporeal membrane oxygen- natology 2013;103:112–117.
6 Beaumier CK, Beres AL, Puligandla PS, Skars- ation and survival in congenital diaphragmat- 25 Houfflin Debarge V, Sicot B, Jaillard S, Gueor-
gard ED; Canadian Pediatric Surgery Net- ic hernia: a center’s 10-year experience. Pre- giva I, Delelis A, Deruelle P, Ducloy AS, Storme
work: Clinical characteristics and outcomes nat Diagn 2010;30:518–521. L: The mechanisms of pain-induced pulmo-
of patients with right congenital diaphrag- 16 Safavi A, Lin Y, Skarsgard ED; Canadian Pe- nary vasoconstriction: an experimental study in
matic hernia: a population-based study. J Pe- diatric Surgery Network: Perinatal manage- fetal lambs. Anesth Analg 2007;104:799–806.
diatr Surg 2015;50:731–733. ment of congenital diaphragmatic hernia: 26 Kamath BD, Fashaw L, Kinsella JP: Adrenal
7 Harting MT, Lally KP: The congenital dia- when and how should babies be delivered? insufficiency in newborns with congenital di-
phragmatic hernia study group registry update. Results from the Canadian Pediatric Surgery aphragmatic hernia. J Pediatr 2010; 156: 495–
Semin Fetal Neonatal Med 2014;19:370–375. Network. J Pediatr Surg 2010;45:2334–2339. 497.e491.
8 Weidner M, Hagelstein C, Debus A, Walleyo 17 Perlman JM, Wyllie J, Kattwinkel J, Atkins 27 Boucherat O, Benachi A, Chailley-Heu B,
A, Weiss C, Schoenberg SO, Schaible T, Bu- DL, Chameides L, Goldsmith JP, Guinsburg Franco-Montoya ML, Elie C, Martinovic J,
sing KA, Kehl S, Neff KW: MRI-based ratio of R, Hazinski MF, Morley C, Richmond S, Si- Bourbon JR: Surfactant maturation is not de-
fetal lung volume to fetal body volume as a mon WM, Singhal N, Szyld E, Tamura M, layed in human fetuses with diaphragmatic
new prognostic marker in congenital dia- Velaphi S; Neonatal Resuscitation Chapter hernia. PLoS Med 2007;4:e237.
phragmatic hernia. AJR Am J Roentgenol Collaborators: Part 11: neonatal resuscitation: 28 Guidry CA, Hranjec T, Rodgers BM, Kane B,
2014;202:1330–1336. 2010 international consensus on cardiopul- McGahren ED: Permissive hypercapnia in the
9 Nasr A, Langer JC; Canadian Pediatric Sur- monary resuscitation and emergency cardio- management of congenital diaphragmatic
gery Network: Influence of location of deliv- vascular care science with treatment recom- hernia: our institutional experience. J Am Coll
UFRJ Universidade Federal do Rio de Janeiro
ery on outcome in neonates with congenital mendations. Circulation 2010;122:S516–S538. Surg 2012;214:640–645; discussion 646–647.
146.164.3.22 - 6/23/2016 8:57:21 PM
DOI: 10.1159/000444210
Downloaded by: